Sugi Predict

Sugi Predict / Compounds / SCHEMBL30427944

SCHEMBL30427944

SCHEMBL30427944

CC(=O)N[C@H]1[C@H](O[C@@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO[C@]2(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O2)O[C@H](CO)[C@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O[C@]2(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O2)[C@H]1O

nearest known ligand 0.71

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ SIGLEC7 Q9Y286 6/20 0.71
▸ MAG P20916 11/20 0.67
▸ SELL P14151 1/20 0.61
▸ SELP P16109 1/20 0.61
▸ SELE P16581 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29615770 0.99 SIGLEC7 (0.73) SIGLEC7MAGSELLSELPSELE
SCHEMBL12472427 0.97 SIGLEC7 (0.73) SIGLEC7MAGSELLSELPSELE
SCHEMBL31668618 0.97 SIGLEC7 (0.75) SIGLEC7MAGSELLSELPSELE
SCHEMBL30652057 0.97 SIGLEC7 (0.73) SIGLEC7MAGSELLSELPSELE
SCHEMBL31717400 0.97 SIGLEC7 (0.73) SIGLEC7MAGSELLSELPSELE
SCHEMBL31717035 0.97 SIGLEC7 (0.73) SIGLEC7MAGSELLSELPSELE
SCHEMBL31701080 0.96 SIGLEC7 (0.74) SIGLEC7MAGSELLSELPSELE
SCHEMBL30650503 0.96 SIGLEC7 (0.74) SIGLEC7MAGSELLSELPSELE
SCHEMBL31701686 0.96 SIGLEC7 (0.72) SIGLEC7MAGSELLSELPSELE
SCHEMBL30970744 0.96 SIGLEC7 (0.75) SIGLEC7MAGSELLSELPSELE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3341411-B1 ANTI-SIGLEC-7 ANTIBODIES AND METHODS OF USE THEREOF ALECTOR LLC (US) 2025-06-11 — — EP disclosed
EP-4149625-A2 TREATMENT OF KNOWN AND UNKNOWN VIRAL INFECTION WITH LIPID AGENTS Viratides, LLC (US) 2023-03-22 — — EP disclosed
Send feedback